SCHEMBL3558542

SCHEMBL3558542

N#CC(=Cc1ccc(-n2ccc(C(F)(F)F)n2)cc1)c1cccc(F)c1F

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.46
RAB9A P51151 6/20 0.46
NPSR1 Q6W5P4 3/20 0.46
HTT P42858 1/20 0.46
PAX8 Q06710 1/20 0.46
MAPT P10636 7/20 0.40
ALDH1A1 P00352 3/20 0.37
PPARD Q03181 2/20 0.35
LMNA P02545 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
POLB P06746 1/20 0.35
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
KDM4E B2RXH2 1/20 0.34
KIF20A O95235 1/20 0.34
MAPK1 P28482 1/20 0.34
F10 P00742 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3558540 1.00 NPC1 (0.46) NPC1RAB9ANPSR1HTTPAX8
SCHEMBL3561937 0.86 NPC1 (0.43) NPC1RAB9ANPSR1HTTPAX8
SCHEMBL3561939 0.86 NPC1 (0.43) NPC1RAB9ANPSR1HTTPAX8
SCHEMBL3554594 0.83 NPC1 (0.46) NPC1RAB9ANPSR1HTTPAX8
SCHEMBL3562064 0.83 NPC1 (0.46) NPC1RAB9ANPSR1HTTPAX8
SCHEMBL3562061 0.83 NPC1 (0.46) NPC1RAB9ANPSR1HTTPAX8
SCHEMBL3554596 0.83 NPC1 (0.46) NPC1RAB9ANPSR1HTTPAX8
SCHEMBL3556322 0.81 ORAI1 (0.41) NPC1RAB9AMAPTALDH1A1PPARD
SCHEMBL13438433 0.81 ORAI1 (0.41) NPC1RAB9AMAPTALDH1A1PPARD
SCHEMBL3563072 0.77 ALDH1A1 (0.35) NPC1RAB9AMAPTALDH1A1PPARD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7705029-B2 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2010-04-27 US disclosed
EP-1732900-A4 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP (US) 2007-12-12 EP disclosed
US-20070270478-A1 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2007-11-22 US disclosed
US-7202232-B2 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. (US) 2007-04-10 US disclosed
EP-1732900-A2 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES Synta Pharmaceuticals Corporation (US) 2006-12-20 EP disclosed
US-20050272699-A1 Acrylonitrile derivatives for inflammation and immune-related uses SYNTA PHARMACEUTICALS CORP. 2005-12-08 US disclosed
WO-2005091752-A2 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES SYNTA PHARMACEUTICALS CORP. (US) 2005-10-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050272699-A1 Acrylonitrile derivatives for inflammation and immune-related uses IL1B, IL6, TLR4 NPC1 601/4885RAB9A 3946/4885NPSR1 1043/4885
US-20070270478-A1 ACRYLONITRILE DERIVATIVES FOR INFLAMMATION AND IMMUNE-RELATED USES IL1B, IL6, TLR4 NPC1 601/4885RAB9A 3946/4885NPSR1 1043/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.